Compare PB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PB | BLCO |
|---|---|---|
| Founded | 1983 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.0B |
| IPO Year | 1998 | 2022 |
| Metric | PB | BLCO |
|---|---|---|
| Price | $72.24 | $17.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | ★ $81.17 | $17.31 |
| AVG Volume (30 Days) | ★ 741.9K | 330.3K |
| Earning Date | 01-28-2026 | 02-18-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 19.26 | N/A |
| EPS | ★ 5.60 | N/A |
| Revenue | $1,239,671,000.00 | ★ $4,976,000,000.00 |
| Revenue This Year | $8.85 | $8.06 |
| Revenue Next Year | $20.65 | $5.79 |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | ★ 7.88 | 6.23 |
| 52 Week Low | $61.07 | $10.45 |
| 52 Week High | $82.75 | $18.14 |
| Indicator | PB | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 51.72 |
| Support Level | $71.22 | $17.18 |
| Resistance Level | $73.59 | $17.50 |
| Average True Range (ATR) | 1.44 | 0.42 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 73.78 | 53.05 |
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.